US Broker Ratings

Supernus Pharmaceuticals, Inc. (SUPN) Stock Analysis: Exploring a Potential 25.73% Upside with Promising CNS Portfolio

Supernus Pharmaceuticals, Inc. (SUPN), a prominent player in the healthcare sector, specializes in developing and commercializing innovative treatments for central nervous system (CNS) diseases. With a market capitalization of $2.8..

Agios Pharmaceuticals (AGIO): Investor Outlook on a Biotech with 30.5% Upside Potential

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its innovative approach to cellular metabolism and promising pipeline of treatments. With a market capitalization of $1.64..

LivaNova PLC (LIVN) Stock Analysis: Promising 9.35% Upside as Healthcare Innovator Surges

LivaNova PLC (NASDAQ: LIVN), the UK-based medical device company, is making waves in the healthcare sector with a robust growth trajectory and an impressive market capitalization of $3.65 billion. Specializing..

CONMED Corporation (CNMD) Stock Analysis: Exploring a 23.95% Potential Upside in the Medical Devices Sector

CONMED Corporation (NASDAQ: CNMD), a key player in the healthcare sector’s medical devices industry, offers intriguing investment potential with a notable 23.95% upside based on current analyst ratings. Headquartered in..

Ocular Therapeutix, Inc. (OCUL) Stock Analysis: Unpacking a 165% Potential Upside in the Biotech Arena

Ocular Therapeutix, Inc. (NASDAQ: OCUL) is capturing investor attention with its compelling potential upside of 165.03%, as analysts set an average target price of $24.25, significantly higher than its current..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Unlocking a 71% Upside Potential in Bioelectric Medicine

Pulse Biosciences, Inc. (NASDAQ: PLSE), a leading player in the bioelectric medicine sector, is capturing the attention of investors with its promising technology and significant upside potential. Despite its current..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: A 16.84% Potential Upside in Medical Devices

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a leading name in the healthcare sector, is capturing the attention of investors with its innovative approach to medical devices, particularly in the field..

The Pennant Group, Inc. (PNTG) Stock Analysis: Analysts Predict 32.88% Upside for Healthcare Innovator

The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector, specifically within the medical care facilities industry. With its headquarters in Eagle, Idaho, and operations spread across..

Evolent Health, Inc. (EVH) Stock Analysis: Exploring a 164.92% Potential Upside in Healthcare Innovation

Evolent Health, Inc. (NYSE: EVH) is a compelling name in the healthcare sector, particularly in the health information services industry. Specializing in specialty care management services across oncology, cardiology, and..

NeoGenomics, Inc. (NEO) Stock Analysis: Growth Potential and Investor Insights

NeoGenomics, Inc. (NYSE: NEO) is carving a significant niche in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $1.59 billion, this U.S.-based company..

U.S. Physical Therapy, Inc. (USPH) Stock Analysis: Exploring a 25.91% Potential Upside in the Healthcare Sector

U.S. Physical Therapy, Inc. (NYSE: USPH) stands out in the healthcare sector, particularly within the medical care facilities industry, with its robust growth trajectory and a promising upside potential for..

Astrana Health Inc. (ASTH) Stock Analysis: Exploring a 60.79% Potential Upside

For investors seeking opportunities in the healthcare sector, Astrana Health Inc. (ASTH) presents a compelling case with its considerable potential upside of 60.79%. As a healthcare management company based in..

Arcellx, Inc. (ACLX) Stock Analysis: Unveiling A 61.73% Potential Upside in Biotechnology

Arcellx, Inc. (NASDAQ: ACLX) stands out in the biotechnology sector with its innovative approach to immunotherapy, aiming to tackle some of the most challenging cancer forms. With a market capitalization..

BioLife Solutions, Inc. (BLFS) Stock Analysis: A 45% Potential Upside Awaits Investors

For investors eyeing the healthcare sector, BioLife Solutions, Inc. (NASDAQ: BLFS) presents itself as a promising opportunity with a projected potential upside of 45.3%. Specializing in innovative bioproduction products and..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Unveiling a 69.88% Upside Potential in the Medical Devices Sector

Alphatec Holdings, Inc. (ATEC), a prominent player in the healthcare sector, specifically in the medical devices industry, is drawing significant attention from investors due to its promising upside potential. With..

Ardent Health, Inc. (ARDT) Stock Analysis: A 52.11% Potential Upside with a Strong Buy Consensus

Investors looking for opportunities in the healthcare sector might find Ardent Health, Inc. (NYSE: ARDT) an intriguing choice. As a prominent player in the medical care facilities industry, Ardent Health..

Indivior Pharmaceuticals (INDV) Stock Analysis: A 30% Upside Opportunity Amidst Promising Drug Innovations

Indivior Pharmaceuticals, Inc. (INDV), a leading player in the healthcare sector specializing in the development of buprenorphine-based prescription drugs, is capturing investor attention with its robust pipeline and a compelling..

Aurinia Pharmaceuticals Inc (AUPH) Stock Analysis: Uncovering the 9.51% Potential Upside

Aurinia Pharmaceuticals Inc (NASDAQ: AUPH) is capturing investor attention with its focused approach in the biotechnology sector, specializing in treatments for autoimmune diseases. As of today, the stock trades at..

Progyny, Inc. (PGNY) Stock Analysis: Healthcare Innovator Offers 27.67% Potential Upside

Progyny, Inc. (NASDAQ: PGNY), a leading player in the healthcare sector, is capturing the attention of investors with its innovative approach to fertility and women’s health benefits. With a substantial..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Exploring a 5.72% Potential Upside

Pediatrix Medical Group, Inc. (NYSE: MD), a prominent player in the healthcare sector, operates within the medical care facilities industry, specializing in newborn and maternal-fetal care services across the United..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds